Travere Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | $555.9K | $19.6K | $10.1K |
| FY2012 | $5.8M | $2.4M | $11.0K |
| FY2013 | $40.2M | $20.5M | $6.0M |
| FY2014 | $172.7M | $135.5M | $18.2M |
| FY2015 | $212.3M | $512.3M | $37.8M |
| FY2016 | $217.5M | $525.3M | $41.0M |
| FY2017 | $227.2M | $520.3M | $99.4M |
| FY2018 | $390.9M | $709.2M | $102.9M |
| FY2019 | $383.6M | $604.8M | $62.4M |
| FY2020 | $396.2M | $607.4M | $84.8M |
| FY2021 | $474.5M | $776.6M | $165.8M |
| FY2022 | $629.7M | $672.6M | $61.7M |
| FY2023 | $588.1M | $788.9M | $58.2M |
| FY2024 | $535.0M | $594.1M | $58.5M |
| FY2025 | $490.4M | $605.2M | $93.0M |